Current issues in Tourette syndrome.
Singer
H S
HS
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000453:epidemiology; D015551:Autoimmunity; D001921:Brain / Q000276:immunology / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D015897:Comorbidity; D003937:Diagnosis, Differential; D020022:Genetic Predisposition to Disease; D006801:Humans; D018377:Neurotransmitter Agents / Q000819:agonists / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D009771:Obsessive-Compulsive Disorder / Q000453:epidemiology; D015995:Prevalence; D012720:Severity of Illness Index; D013981:Tic Disorders / Q000175:diagnosis / Q000453:epidemiology*; D005879:Tourette Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D018377:Neurotransmitter Agents